This site is part of the Informa Connect Division of Informa PLC

Informa PLC
About Us
Investor relations
Talent

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

April 27, 2023

Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST

Home

What's On? Agenda
Our Speakers
Industry Spotlight
Enquiries & Customer Services
Sponsors & Exhibitors
Digital Experience

April 27, 2023

Digital Conference8:00AM EDT // 1:00PM BST // 2:00PM CEST

Speakers

Streams

Influenza mRNA Vaccines

Topics

Academic Spotlight: Highlighting the Ground-breaking Work from Leading Academic Institutions

Integrating CMC and Analytical Considerations into the Design Process for Seamless Production and Roll-out

The Future of mRNA-based Flu Vaccines: How Far Away is This Reality?

Utilizing the Triumphs and Lessons Learned from COVID: What Makes a Successful mRNA Vaccine?

Search & Filter

Hide

Search & Filter

Streams

Influenza mRNA Vaccines

Topics

Academic Spotlight: Highlighting the Ground-breaking Work from Leading Academic Institutions

Integrating CMC and Analytical Considerations into the Design Process for Seamless Production and Roll-out

The Future of mRNA-based Flu Vaccines: How Far Away is This Reality?

Utilizing the Triumphs and Lessons Learned from COVID: What Makes a Successful mRNA Vaccine?

Martin Friede

Coordinator, Initiative for Vaccine Research (IVR)

World Health Organisation, Switzerland

Raffael Nachbagauer

Program Leader & Executive Director, Infectious Disease Development

Moderna, USA

Norbert Pardi

Research Assistant Professor of Medicine

University of Pennsylvania, USA

Lawrence Thompson

Associate Research Fellow

Pfizer, USA

John S Tregoning

Reader in Respiratory Infections

Imperial College London, UK

Jane True

VP, mRNA Commercial Strategy & Innovation and Global Pandemic Security Lead

Pfizer, USA

Amita Vaidya

Principal Scientist, Delivery and Formulations, Sanofi mRNA Centre of Excellence

Sanofi, USA

Filter

Streams

Influenza mRNA Vaccines

Topics

Academic Spotlight: Highlighting the Ground-breaking Work from Leading Academic Institutions

Integrating CMC and Analytical Considerations into the Design Process for Seamless Production and Roll-out

The Future of mRNA-based Flu Vaccines: How Far Away is This Reality?

Utilizing the Triumphs and Lessons Learned from COVID: What Makes a Successful mRNA Vaccine?

Home
Contact
Privacy
Terms of Use
Terms & Conditions
CCPA: Do not sell my personal info